This compound is a fluorinated nitroquinazoline derivative used as a pharmaceutical intermediate in the manufacturing of afatinib impurities. Its structure features multiple halogen and amine functional groups, contributing to its role in research and development.
Alcance del contenido: La información de esta página se refiere a la identificación química y a los contextos de suministro industrial, investigación y producción. No constituye una afirmación terapéutica, un consejo médico ni instrucciones de uso de medicamentos.
¿Adquiriendo o suministrando este compuesto?
Publique su inventario o una solicitud de compra
CAS 2226537-61-5
N-(4-Chloro-3-fluorophenyl)-7-fluoro-6-nitroquinazolin-4-amine
pharmaceutical intermediate
N-(3-chloro-4-fluorophenyl)-7-fluoro-6-nitroquinazolin-4-amine
Pharmaceutical intermediate for drug synthesis
N-(3,4-Dichlorophenyl)-7-fluoro-6-nitroquinazolin-4-amine
impurity reference standard for afatinib
(R)-N-(4-((3-Chloro-4-fluorophenyl)amino)-7-(((R)-tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4-(dimethylamino)-3-hydroxybutanamide
Pharmaceutical intermediate for afatinib impurities
(R)-N-(3-Chloro-4-fluorophenyl)-6-nitro-7-((tetrahydrofuran-3-yl)oxy)quinazolin-4-amine
Pharmaceutical intermediate for afatinib impurities
2-Bromo-5-(4-cyanophenoxy)benzyl acetate
Pharmaceutical intermediate
Methyl 4-[(1S)-1-aminoethyl]benzoate
pharmaceutical intermediate
(R)-7,8-Difluoro-6,11-dihydrodibenzo[b,e]thiepin-11-ol
Pharmaceutical intermediate for synthesis
N-(3,4-difluorophenyl)-7-fluoro-6-nitroquinazolin-4-amine
DZRYHCITHKPDFS-UHFFFAOYSA-N
C1=CC(=C(C=C1NC2=NC=NC3=CC(=C(C=C32)[N+](=O)[O-])F)F)F
—